Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH and Ketone Bodies Infusion in Healthy Men
NCT02655263Completed
- Sponsor
- Aarhus University
- Start
- Jan 2016
- Primary completion
- Oct 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of somatropin (3 arms), sponsored by Aarhus University. Primary endpoint: Insulin and growth hormone signaling, expressed as CHANGE in phosphorylation of intracellular target proteins in muscle- and fat-tissue. Started Jan 2016; status: completed.
02
Drugs
somatropin
Beyond the preview
Go deeper on NCT02655263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655263.